Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care and who reported a positive experience.
This measure will consist of two performance rates:
AQI48a: Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care
AQI48b: Percentage of patients, aged 18 and older, who completed a survey on their patient experience and satisfaction with anesthesia care who report a positive experience with anesthesia care within 60 days of receipt of the survey.
NOTE: The measure requires that a valid survey, as defined in the numerator of AQI48a, be sent to patients between discharge from the facility and within 30 days of facility discharge. To report AQI48b, a minimum number of 20 surveys with the mandatory question completed must be reported. ** In order to be scored on this measure, clinicians must report BOTH AQI48a AND AQI48b.
Percentage of patients with patient-reported meaningful improvement in anatomic specific HOOS/KOOS JR after elective total hip and knee arthroplasty.
Percentage of patients with patient-reported meaningful improvement in pain following lumbar or cervical spine procedures
The percentage of patients aged 18 and older with at least one clinician encounter (including telehealth) during the measurement period and an active diagnosis of gout treated with urate-lowering therapy (ULT) for at least 12 months, whose most recent serum urate result is less than 6.0 mg/dL.
If a patient is using hydroxychloroquine, then the average daily dose should be less than or equal to 5 mg/kg.
Percentage of patients aged 18 years or older with a diagnosis of RA AND receiving a first course therapy using a biologic disease-modifying antirheumatic drug (DMARD) who had a prescription for a conventional synthetic (cs) DMARD at least 10 weeks prior to newly initiated biologic therapy during the measurement year.
Weighted average of 3 former QCDR measures, ACRad 31, ACRad 32, ACRad 33.
Percentage of final reports for any chest CT examinations (non-cardiac, with or without contrast) performed on patients, aged 18 and older, that:
1. Document the presence or absence of coronary artery calcification (CAC),
2. If CAC is present, include documentation of a qualitative visual assessment of CAC and a recommendation that the patient consult with their primary care clinician for a comprehensive cardiovascular risk assessment, or a quantitative ordinal assessment of CAC for each of the four main coronary arteries. Recommendations for cardiovascular risk assessment should accompany any non-zero score.
Percentage of final reports for patients aged 18 years and older undergoing CT pulmonary angiography (CTPA) with a finding of PE that specify the branching order level of the most proximal level of embolus (i.e. main, lobar, interlobar, segmental, subsegmental); AND right ventricle to left ventricle (RV/LV) ratio, when assessable. If the RV/LV ratio is ?1.0, report the specific ratio value, as this may be associated with increased risk for adverse outcomes, and if the RV/LV ratio is <1.0, report that the ratio is within normal limits, optionally including a range (e.g., 0.7-0.9) to support clinical context.
Percentage of final reports for patients with acute spinal fractures undergoing initial CT of the spine that include descriptive imaging findings.
